Your browser doesn't support javascript.
loading
[Efficacy of additional two cycles of rituximab administration for patients with diffuse large B-cell lymphoma in first remission].
Zhong, H J; Xu, P P; Zhao, W L.
Affiliation
  • Zhong HJ; Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Zhonghua Xue Ye Xue Za Zhi ; 37(9): 756-761, 2016 Sep 14.
Article in Zh | MEDLINE | ID: mdl-27719717

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Antibodies, Monoclonal, Murine-Derived / Rituximab Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2016 Document type: Article Affiliation country: China Country of publication: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Antibodies, Monoclonal, Murine-Derived / Rituximab Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2016 Document type: Article Affiliation country: China Country of publication: China